India's primary market calendar registers seven listings and one new SME issue this week, marking the first sustained IPO activity since the December freeze. CMR Green Technologies and Hexagon Nutrition anchor the mainboard slate, both targeting institutional allocators who sat out the prior three months.
The two companies represent ₹800 crore to ₹1,200 crore in combined fresh issuance, according to draft filings reviewed last month. CMR Green operates renewable energy infrastructure with contracted power purchase agreements across four states. Hexagon Nutrition manufactures clinical nutrition products under licensing arrangements with multinational pharmaceutical groups. Both offerings include anchor rounds reserved for qualified institutional buyers, a structure that signals underwriters expect orderbook coverage north of three times at the price band floor.
Demand indicators matter because the January window failed. Three scheduled mainboard IPOs postponed after anchor books came back undersubscribed. The SME segment continued issuing, but grey market premiums compressed to single digits, suggesting retail participation dried up. This week's dual launch tests whether allocators will pay for earnings visibility in a macro environment where the Reserve Bank of India held rates steady and fiscal spending remains constrained ahead of state elections. If either offering prices at the upper band and lists above issue price, the underwriting calendar through March will fill quickly.
The revival also changes the venture exit math. Late-stage funds holding positions in companies that filed draft prospectuses in Q4 2024 now have a live comparable set for valuation discussions. Secondary sale components in both CMR Green and Hexagon Nutrition offerings will establish clearing prices for similar asset profiles. Pre-IPO investors in renewable infrastructure and pharmaceutical supply chains should note: if these issues trade flat or down in the first week, subsequent filings will reprice downward by 15% to 20% to ensure allocation. The window for exiting at 2023 valuations closes fast.
Operators should track three events. First, anchor allocation results release 48 hours before the retail subscription window opens, typically late Tuesday or early Wednesday this week. Undersubscription there kills momentum. Second, grey market premium trends in the 72 hours surrounding listing day indicate whether flippers dominate the orderbook or longer-term holders are building positions. Third, watch for SEBI filing activity in the next 10 days—if four or more new draft prospectuses appear, underwriters believe the window will hold through quarter-end.
The SME issue opening this week remains unnamed in public disclosures, but the BSE SME platform shows one technology services company in the final approval stage. That segment's performance diverged from mainboard in Q4, with median listing gains of 22% against mainboard's 8%, suggesting retail capital migrated downmarket when institutional issues stalled. If that pattern holds, the SME listing may outperform the mainboard pair, which would be the wrong signal for capital formation at scale.